Allergan Inc. (Historical) and Google Finance

Allergan Inc. was a global pharmaceutical company renowned for its development and marketing of brand-name pharmaceuticals, medical devices, and over-the-counter products. It was particularly well-known for Botox (onabotulinumtoxinA), a neurotoxin used for both cosmetic and therapeutic purposes. Allergan also had a significant presence in eye care, including treatments for glaucoma, dry eye, and other ophthalmic conditions.

However, Allergan Inc. no longer exists as an independent publicly traded entity. In May 2020, Allergan was acquired by AbbVie, a global biopharmaceutical company. The acquisition significantly expanded AbbVie’s portfolio and diversified its revenue streams.

Allergan’s Stock Performance (Pre-Acquisition)

Prior to its acquisition, Allergan’s stock (AGN) was tracked on various financial platforms, including Google Finance. Google Finance provided investors with real-time stock quotes, historical data, news, and financial analysis related to Allergan. Investors could use Google Finance to monitor the stock’s performance, track its price fluctuations, and access key financial metrics such as earnings per share (EPS), price-to-earnings (P/E) ratio, and dividend yield (if applicable). They could also examine Allergan’s historical performance over various timeframes, from daily charts to multi-year analyses.

The performance of Allergan’s stock on Google Finance reflected the company’s overall financial health and investor sentiment. Events such as new drug approvals, clinical trial results, regulatory approvals, and earnings announcements could all significantly impact the stock price. Furthermore, broader economic trends and industry-specific developments in the pharmaceutical and healthcare sectors influenced the stock’s valuation.

Google Finance and Post-Acquisition Data

Following the acquisition of Allergan by AbbVie, the Allergan Inc. (AGN) ticker symbol was delisted from major stock exchanges. As a result, real-time stock quotes and trading data for Allergan ceased to be available on Google Finance. However, Google Finance typically retains historical data for delisted companies, allowing users to access information about Allergan’s past stock performance.

To understand the current market dynamics and financial performance of the businesses that once comprised Allergan, investors would now focus on AbbVie’s stock (ABBV) on Google Finance. AbbVie’s financial statements and investor relations materials would reflect the integrated performance of Allergan’s former assets and operations.

Using Google Finance for Research

Even though Allergan is no longer a separate entity, researchers and investors can still utilize Google Finance to access historical data and analyze past performance. This information can be valuable for understanding industry trends, evaluating the success of mergers and acquisitions, and developing investment strategies. When researching Allergan, it’s crucial to remember that the data represents a snapshot in time and does not reflect the current state of the combined AbbVie-Allergan business.

Google Finance remains a useful tool for accessing historical stock data and financial information. However, it’s imperative to verify information and consult reputable financial news sources and company filings for the most up-to-date and accurate details.